Literature DB >> 29080150

In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study.

Stylianos A Pyxaras1,2, Tom Adriaenssens3,4, Emanuele Barbato1, Giovanni Jacopo Ughi3,4, Luigi Di Serafino1, Frederic De Vroey1, Gabor Toth5, Shengxian Tu6,7, Johan H C Reiber6, Jeroen J Bax8, William Wijns9,10,11.   

Abstract

We sought to assess in-stent variations in fractional flow reserve (FFR) in patients with previous percutaneous coronary intervention (PCI) and to associate any drop in FFR with findings by optical coherence tomography (OCT) imaging. Suboptimal post-PCI FFR values were previously associated with poor outcomes. It is not known to which extent in-stent pressure loss contributes to reduced FFR. In this single-arm observational study, 26 patients who previously underwent PCI with drug-eluting stent or scaffold implantation were enrolled. Motorized FFR pullback during continuous intravenous adenosine infusion and OCT assessments was performed. Post-PCI FFR < 0.94 was defined as suboptimal. At a median of 63 days after PCI (interquartile range: 59-64 days), 18 out of 26 patients (72%) had suboptimal FFR. The in-stent drop in FFR was significantly higher in patients with suboptimal FFR vs. patients with optimal FFR (0.08 ± 0.07 vs. 0.01 ± 0.02, p < 0.001). Receiver operating characteristic curve analysis showed that an in-stent FFR variation of > 0.03 was associated with suboptimal FFR. In patients with suboptimal FFR, the OCT analyses revealed higher mean neointimal area (respectively: 1.06 ± 0.80 vs. 0.51 ± 0.23 mm2; p = 0.018) and higher neointimal thickness of covered struts (respectively 0.11 ± 0.07 vs. 0.06 ± 0.01 mm; p = 0.021). Suboptimal FFR values following stent-implantation are mainly caused by significant in-stent pressure loss during hyperemia. This finding is associated to a larger neointimal proliferation.

Entities:  

Keywords:  Drug-eluting stent; Fractional flow reserve; Optical coherence tomography; Percutaneous coronary intervention; Stable coronary artery disease

Mesh:

Substances:

Year:  2017        PMID: 29080150     DOI: 10.1007/s10554-017-1262-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

1.  In vitro study of FFR, QCA, and IVUS for the assessment of optimal stent deployment.

Authors:  K Matthys; S Carlier; P Segers; J Ligthart; G Sianos; P Serrano; P R Verdonck; P W Serruys
Journal:  Catheter Cardiovasc Interv       Date:  2001-11       Impact factor: 2.692

2.  Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.

Authors:  Nico H J Pijls; Volker Klauss; Uwe Siebert; Eric Powers; Kenji Takazawa; William F Fearon; Javier Escaned; Yukio Tsurumi; Takashi Akasaka; Habib Samady; Bernard De Bruyne
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

3.  Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.

Authors:  Francesco Prati; Enrico Romagnoli; Francesco Burzotta; Ugo Limbruno; Laura Gatto; Alessio La Manna; Francesco Versaci; Valeria Marco; Luca Di Vito; Fabrizio Imola; Giulia Paoletti; Carlo Trani; Corrado Tamburino; Luigi Tavazzi; Gary S Mintz
Journal:  JACC Cardiovasc Imaging       Date:  2015-11

4.  Optimization of Tryton dedicated coronary bifurcation system with coregistration of optical coherence tomography and fractional flow reserve.

Authors:  Stylianos A Pyxaras; Shengxian Tu; Emanuele Barbato; Johan H C Reiber; William Wijns
Journal:  JACC Cardiovasc Interv       Date:  2013-07       Impact factor: 11.195

5.  Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition.

Authors:  Jun Tanigawa; Peter Barlis; Carlo Di Mario
Journal:  EuroIntervention       Date:  2007-05       Impact factor: 6.534

6.  Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements.

Authors:  Josep Rodés-Cabau; Marcos Gutiérrez; Javier Courtis; Eric Larose; Jean-Pierre Déry; Mélanie Côté; Can Mahn Nguyen; Onil Gleeton; Guy Proulx; Louis Roy; Bernard Noël; Gerald Barbeau; Robert De Larochellière; Stéphane Rinfret; Olivier F Bertrand
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

7.  Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography.

Authors:  B De Bruyne; F Hersbach; N H Pijls; J Bartunek; J W Bech; G R Heyndrickx; K L Gould; W Wijns
Journal:  Circulation       Date:  2001-11-13       Impact factor: 29.690

8.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition.

Authors:  Nicolas Foin; Juan Luis Gutiérrez-Chico; Shimpei Nakatani; Ryo Torii; Christos V Bourantas; Sayan Sen; Sukhjinder Nijjer; Ricardo Petraco; Chrysa Kousera; Matteo Ghione; Yoshinobu Onuma; Hector M Garcia-Garcia; Darrel P Francis; Philip Wong; Carlo Di Mario; Justin E Davies; Patrick W Serruys
Journal:  Circ Cardiovasc Interv       Date:  2014-03-18       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.